Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.

By G. Clifford, J. Polesel, M. Rickenbach, L. Dal Maso, O. Keiser, A. Kofler, E. Rapiti, F. Levi, G. Jundt, T. Fisch and 3 more. Journal of the National Cancer Institute, 2005

899 citations recorded by the source corpus.

Subfields: Epidemiology, Oncology, Otorhinolaryngology

View Paper: https://www.semanticscholar.org/paper/76b4643445e95a26d41f0f764df17bdf60ebc735

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. E. Engels
2. J. Goedert
3. R. Biggar
4. F. Bray
5. G. Clifford

In Oncology

1. E. Engels
2. J. Goedert
3. R. Biggar
4. F. Bray
5. J. Ferlay

In Otorhinolaryngology

1. E. Engels
2. J. Goedert
3. R. Biggar

Citations in the corpus

• iArc monogrAphs on the evAluAtion oF cArcinogenic risks to humAns (2012, background): “Studies that assessed the risk of lung cancer in HIV-1-infected people according to individual antiretroviral treatment failed to demonstrate an effect of HAART on lung cancer risk, thus indicating that lung cancer is not strongly associated with severe immunosuppression (Clifford et al., 2005; Serr”
• Cancer risk in people infected with human immunodeficiency virus in the United States (2008, background): “Likewise, we classified the 1-year intervals according to whether the interval began in 1991–1995 or 1996–2002, as an indication of the availability of HAART.”
• Trends in cancer risk among people with AIDS in the United States 1980–2002 (2006, background): “Previous studies have reported an elevated risk of lung cancer in HIV-infection [7,10–12,28–30], with inconclusive results regarding possible changes over time or relationship to HAARTuse [7,28–30].”
• Estimates of the global burden of cervical cancer associated with HIV (2020, background): “Clifford et al.(12) 2005 Switzerland cohort study 1985–2003 Swiss HIV Cohort Study and Swiss cantonal cancer registries — — 26% — — No”